Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · IEX Real-Time Price · USD
1.780
-0.040 (-2.20%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Aerovate Therapeutics Employees
Aerovate Therapeutics had 51 employees as of December 31, 2023. The number of employees increased by 8 or 18.60% compared to the previous year.
Employees
51
Change (1Y)
8
Growth (1Y)
18.60%
Revenue / Employee
n/a
Profits / Employee
-$1,611,510
Market Cap
51.30M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51 | 8 | 18.60% |
Dec 31, 2022 | 43 | 27 | 168.75% |
Dec 31, 2021 | 16 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
Atara Biotherapeutics | 225 |
Barinthus Biotherapeutics | 130 |
DURECT | 58 |
LAVA Therapeutics | 37 |
vTv Therapeutics | 16 |
Ocuphire Pharma | 14 |
Reneo Pharmaceuticals | 8 |
AVTE News
- 14 days ago - Aerovate Therapeutics to Explore Strategic Alternatives - GlobeNewsWire
- 4 weeks ago - Investigation Into Aerovate Therapeutics, Inc. (AVTE) Announced byHolzer & Holzer, LLC - GlobeNewsWire
- 4 weeks ago - Aerovate Therapeutics Investors: Investigation on behalf of investors; the Portnoy Law Firm - GlobeNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Aerovate Therapeutics Investigated for Securities Fraud Violations by Block & Leviton - GlobeNewsWire
- 5 weeks ago - Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension - GlobeNewsWire
- 2 months ago - Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference - GlobeNewsWire
- 2 months ago - Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference - GlobeNewsWire